Holen Sie sich die Stockscreener-App
4.122
1.78%
0.072
Schlusskurs vom Vortag:
$4.05
Offen:
$4.02
24-Stunden-Volumen:
8,705
Relative Volume:
0.30
Marktkapitalisierung:
$7.91M
Einnahmen:
$5.20M
Nettoeinkommen (Verlust:
$-42.68M
KGV:
-0.2454
EPS:
-16.7991
Netto-Cashflow:
$-47.20M
1W Leistung:
-4.14%
1M Leistung:
-16.73%
6M Leistung:
-20.40%
1J Leistung:
-50.78%
1-Tages-Spanne:
$4.02
$4.3299
1-Wochen-Bereich:
$4.01
$4.375
52-Wochen-Spanne:
$4.01
$9.66
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Firmenname
Bolt Biotherapeutics Inc
Sektor
Branche
Telefon
650-665-9295
Adresse
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
4.122 | 7.77M | 5.20M | -42.68M | -47.20M | -16.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.80 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.16 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.52 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.65 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.37 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Eingeleitet | Guggenheim | Buy |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
HC Wainwright Reiterates Buy Rating for Bolt Biotherapeutics (BO - GuruFocus
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - theheraldreview.com
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Bitget
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Bolt Biotherapeutics Inc.: Fourth Quarter Financial Results Overview - Bitget
BOLT Reports Q4 Revenue Surpassing Expectations - GuruFocus
Bolt Biotherapeutics 10-K: $7.7M Revenue, $(17.85) EPS - TradingView
Take Profit: Is Bolt Biotherapeutics Inc a speculative investmentMarket Volume Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Can Bolt Biotherapeutics Inc. stock maintain growth trajectoryEarnings Recap Report & Real-Time Market Trend Scan - Naître et grandir
Is Bolt Biotherapeutics Inc. (6LP0) stock overpriced at current multiplesDividend Hike & Step-by-Step Swing Trade Plans - Naître et grandir
BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Is Bolt Biotherapeutics Inc likely to announce a buybackJuly 2025 Technicals & Reliable Trade Execution Plans - baoquankhu1.vn
BOLT SEC FilingsBolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Portfolio Update: Will Bolt Biotherapeutics Inc announce a stock splitJuly 2025 Selloffs & Reliable Intraday Trade Alerts - baoquankhu1.vn
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Bolt Biotherapeutics to Participate in Upcoming March Conferences - Bitget
Ideas Watch: Is Bolt Biotherapeutics Inc a speculative investmentProduct Launch & Technical Pattern Alert System - baoquankhu1.vn
BOLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Layoff Tracker: Concerto Downsizes Amid Pivot to Consumer; Faraday Closes Down - BioSpace
Recap Report: Is TIM SA Depositary Receipt stock a hidden gemWeekly Profit Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. impacted by rising ratesIndex Update & Weekly Setup with ROI Potential - mfd.ru
Is Bolt Biotherapeutics Inc. likely to announce a buybackRecession Risk & Smart Money Movement Alerts - mfd.ru
Why Bolt Biotherapeutics Inc. (6LP0) stock stays undervaluedTrade Signal Summary & Community Supported Trade Ideas - mfd.ru
Is Bolt Biotherapeutics Inc. stock forming a cup and handleJuly 2025 Earnings & Intraday High Probability Setup Alerts - mfd.ru
Is Bolt Biotherapeutics Inc. a speculative investmentJuly 2025 WrapUp & Daily Profit Focused Screening - mfd.ru
H.C. Wainwright Raises Protagonist Therapeutics, Inc. (PTGX) Target to $117, Reiterates Buy - Finviz
Treasury Yields: Is Bolt Biotherapeutics Inc. a top pick in the sectorPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Radiopharm Theranostics (NASDAQ:RADX) versus Bolt Biotherapeutics (NASDAQ:BOLT) Head-To-Head Survey - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Bolt Biotherapeutics (NASDAQ:BOLT) Stock Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Growth Review: What are the analyst revisions for Bolt Biotherapeutics Inc.Is ZKIN stock a good investment in YEARDollar Strength & Low Risk High Reward Ideas - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. still a buy after recent gains2025 Momentum Check & Free High Accuracy Swing Entry Alerts - mfd.ru
Insider Trends: What is the long term forecast for Bolt Biotherapeutics Inc stockJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Risk Recap: Can ETRACS 2x Leveraged US Value Factor TR ETN maintain sales growth2025 Trade Ideas & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Nasdaq Moves: Whats the outlook for Bolt Biotherapeutics Incs sector2025 Valuation Update & Technical Confirmation Trade Alerts - baoquankhu1.vn
Bolt (Fastener) Market Covering Prime Factors and Competitive - openPR.com
Risks Report: What are the analyst revisions for Bolt Biotherapeutics IncIs ZKIN stock a good investment in YEARMarket Growth Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Weekly Recap: Can Quince Therapeutics Inc sustain its profitabilityJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Portfolio Shifts: Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Aug Final Week: Does ELAB stock reflect fundamentalsBull Run & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Bolt appoints Olta Andoni as SVP of legal and people to support platform expansion across checkout, identity, and payments - marketscreener.com
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 83.8% in December - Defense World
Aug Analyst Calls: What momentum indicators show for Bolt Biotherapeutics Inc stockQuarterly Portfolio Report & AI Forecasted Stock Moves - Bộ Nội Vụ
Entry Recap: Will Bolt Biotherapeutics Inc. (6LP0) stock enhance shareholder valueMarket Volume Report & Advanced Technical Signal Analysis - Bộ Nội Vụ
Portfolio Shifts: Is Bolt Biotherapeutics Inc undervalued by DCF analysisJuly 2025 Chart Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Analyst Calls: Why Bolt Biotherapeutics Inc 6LP0 stock fits value portfoliosJuly 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Can Bolt Biotherapeutics Inc. stock continue upward trendWeekly Investment Summary & Real-Time Market Sentiment Alerts - Улправда
Will Bolt Biotherapeutics Inc. stock outperform tech sector in 2025Contrarian Investment Ideas & High Return Trading Strategies - bollywoodhelpline.com
Why Bolt Biotherapeutics Inc. (6LP0) stock fits value portfoliosPortfolio Profit Report & AI Driven Stock Movement Reports - ulpravda.ru
Can Bolt Biotherapeutics Inc. (6LP0) stock hold up in economic slowdownExit Point & Consistent Income Trade Ideas - ulpravda.ru
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):